These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 29091774)
1. Differential Regulation of G1 CDK Complexes by the Hsp90-Cdc37 Chaperone System. Hallett ST; Pastok MW; Morgan RML; Wittner A; Blundell KLIM; Felletar I; Wedge SR; Prodromou C; Noble MEM; Pearl LH; Endicott JA Cell Rep; 2017 Oct; 21(5):1386-1398. PubMed ID: 29091774 [TBL] [Abstract][Full Text] [Related]
2. Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins. Smith JR; de Billy E; Hobbs S; Powers M; Prodromou C; Pearl L; Clarke PA; Workman P Oncogene; 2015 Jan; 34(1):15-26. PubMed ID: 24292678 [TBL] [Abstract][Full Text] [Related]
3. Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4. Stepanova L; Leng X; Parker SB; Harper JW Genes Dev; 1996 Jun; 10(12):1491-502. PubMed ID: 8666233 [TBL] [Abstract][Full Text] [Related]
4. Atomistic simulations and network-based modeling of the Hsp90-Cdc37 chaperone binding with Cdk4 client protein: A mechanism of chaperoning kinase clients by exploiting weak spots of intrinsically dynamic kinase domains. Czemeres J; Buse K; Verkhivker GM PLoS One; 2017; 12(12):e0190267. PubMed ID: 29267381 [TBL] [Abstract][Full Text] [Related]
5. Clinical CDK4/6 inhibitors induce selective and immediate dissociation of p21 from cyclin D-CDK4 to inhibit CDK2. Pack LR; Daigh LH; Chung M; Meyer T Nat Commun; 2021 Jun; 12(1):3356. PubMed ID: 34099663 [TBL] [Abstract][Full Text] [Related]
6. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Reynisdóttir I; Polyak K; Iavarone A; Massagué J Genes Dev; 1995 Aug; 9(15):1831-45. PubMed ID: 7649471 [TBL] [Abstract][Full Text] [Related]
7. Identification of a conserved sequence motif that promotes Cdc37 and cyclin D1 binding to Cdk4. Zhao Q; Boschelli F; Caplan AJ; Arndt KT J Biol Chem; 2004 Mar; 279(13):12560-4. PubMed ID: 14701845 [TBL] [Abstract][Full Text] [Related]
9. Interaction between Cdc37 and Cdk4 in human cells. Lamphere L; Fiore F; Xu X; Brizuela L; Keezer S; Sardet C; Draetta GF; Gyuris J Oncogene; 1997 Apr; 14(16):1999-2004. PubMed ID: 9150368 [TBL] [Abstract][Full Text] [Related]
10. Hsp90-dependent activation of protein kinases is regulated by chaperone-targeted dephosphorylation of Cdc37. Vaughan CK; Mollapour M; Smith JR; Truman A; Hu B; Good VM; Panaretou B; Neckers L; Clarke PA; Workman P; Piper PW; Prodromou C; Pearl LH Mol Cell; 2008 Sep; 31(6):886-95. PubMed ID: 18922470 [TBL] [Abstract][Full Text] [Related]
11. Hsp90·Cdc37 Complexes with Protein Kinases Form Cooperatively with Multiple Distinct Interaction Sites. Eckl JM; Scherr MJ; Freiburger L; Daake MA; Sattler M; Richter K J Biol Chem; 2015 Dec; 290(52):30843-54. PubMed ID: 26511315 [TBL] [Abstract][Full Text] [Related]
12. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells. Said TK; Medina D Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257 [TBL] [Abstract][Full Text] [Related]
13. Ensemble-based modeling and rigidity decomposition of allosteric interaction networks and communication pathways in cyclin-dependent kinases: Differentiating kinase clients of the Hsp90-Cdc37 chaperone. Stetz G; Tse A; Verkhivker GM PLoS One; 2017; 12(11):e0186089. PubMed ID: 29095844 [TBL] [Abstract][Full Text] [Related]
14. Functional Role and Hierarchy of the Intermolecular Interactions in Binding of Protein Kinase Clients to the Hsp90-Cdc37 Chaperone: Structure-Based Network Modeling of Allosteric Regulation. Stetz G; Verkhivker GM J Chem Inf Model; 2018 Feb; 58(2):405-421. PubMed ID: 29432007 [TBL] [Abstract][Full Text] [Related]
15. ATP-competitive inhibitors block protein kinase recruitment to the Hsp90-Cdc37 system. Polier S; Samant RS; Clarke PA; Workman P; Prodromou C; Pearl LH Nat Chem Biol; 2013 May; 9(5):307-12. PubMed ID: 23502424 [TBL] [Abstract][Full Text] [Related]
16. Cdc37-Hsp90 complexes are responsive to nucleotide-induced conformational changes and binding of further cofactors. Gaiser AM; Kretzschmar A; Richter K J Biol Chem; 2010 Dec; 285(52):40921-32. PubMed ID: 20880838 [TBL] [Abstract][Full Text] [Related]
17. Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib. Poratti M; Marzaro G Eur J Med Chem; 2019 Jun; 172():143-153. PubMed ID: 30978559 [TBL] [Abstract][Full Text] [Related]
18. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase. Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508 [TBL] [Abstract][Full Text] [Related]
19. Structure of an Hsp90-Cdc37-Cdk4 complex. Vaughan CK; Gohlke U; Sobott F; Good VM; Ali MM; Prodromou C; Robinson CV; Saibil HR; Pearl LH Mol Cell; 2006 Sep; 23(5):697-707. PubMed ID: 16949366 [TBL] [Abstract][Full Text] [Related]
20. Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitors. Smith JR; Clarke PA; de Billy E; Workman P Oncogene; 2009 Jan; 28(2):157-69. PubMed ID: 18931700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]